Search
Advancing the Science of Real-World Data to Address the COVID-19 Pandemic - 09/10/2020 - 09/10/2020
… /fda-grand-rounds/advancing-science-real-world-data-address-covid-19-pandemic-09102020-09102020 … About the Presentation: The … FDA continues to work around the clock to respond to the COVID-19 pandemic. As part of this effort, we recognize the …
Studies of SARS-CoV-2 NSP1 and Envelope Protein - 03/11/2021 - 03/11/2021
… Microbiology at NCTR. About the Presentation: To elucidate COVID-19 pathogenesis and develop a successful treatment will … Recording … Office of the Commissioner … To elucidate COVID-19 pathogenesis and develop a successful treatment will …
FDA CERSI Lecture on Long COVID: Risk factors, Symptomology and Patient Reported Outcomes Captured Through a Novel Digital Platform by Dr. Erica Spatz & Dr. Kelli O’Laughlin - 11/09/2021 - 11/09/2021
… Health About the Presentation While most people with COVID-19 have resolution of their symptoms within weeks of … long COVID, long-haul COVID, post-acute sequelae of COVID-19, long-term effects of COVID, or chronic COVID. Post-COVID …
Vaccine outcomes to SARS-CoV-2 vaccine and variant viruses among pregnant people by Sabra Klein - 03/19/2024
… severe outcomes from many infectious diseases, including COVID-19. Pregnant patients, however, were not included in initial … cellular, and immunometabolic immune responses to COVID-19 mRNA vaccines in pregnant compared with non-pregnant …
Some Perspectives on Data Science and Coronaviruses - 06/09/2022
… … About the Speaker Seshadri S. Vasan, DPhil (Oxon) COVID-19 Science Leader, CSIRO, Australia Honorary Professor, … University of York, UK Dr. Seshadri S. Vasan , is a COVID-19 Science Leader for Australia’s science agency CSIRO, …
SARS-CoV-2: Host-pathogen interaction, vaccines & variants of concern - 07/08/2021 - 07/08/2021
… focus of his work is on SARS-CoV-2 (the caustive agent of COVID-19). Because of his coronavirus experience he is a co-opted … infection which will help in future treatments of COVID-19 patients. They will also present results on the …
Airborne Respiratory Viral Infections and Non-Pharmaceutical Interventions - 06/14/2022
… to inhalation of viral aerosols as a major driver of the COVID-19 pandemic rekindling interest in understanding airborne …
Assessment of Safety and Efficacy of Fecal Microbiota for Transplantation Products - 12/10/2020 - 12/10/2020
… we have been working to understand the impact of the COVID-19 pandemic on this class of products as SARS-CoV-2 viral RNA …
Precisely practicing medicine for COVID, from a half million tested patients and a trillion points of data - 03/10/2021 - 03/10/2021
… practice medicine, especially during in this era of COVID-19. About the Presenter Atul Butte, MD, PhD is the … CERSI Lecture on Precisely practicing medicine for COVID, from a half million tested patients and a trillion …
2020 Winners of the America's Got Regulatory Science Talent Present at FDA - 04/06/2020 - 04/06/2020
… … Due to COVID-19 this event was online only. Since 2013, the University of …
CERSI Program Showcase - 10/05/2023
… pm Metabolism-based DDI and liver toxicity of drugs for COVID-19 treatment Hongbing Wang, PhD; University of Maryland 4:15 …